{"id":2511,"date":"2019-10-06T14:56:14","date_gmt":"2019-10-06T12:56:14","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=2511"},"modified":"2024-04-19T10:11:04","modified_gmt":"2024-04-19T08:11:04","slug":"infections-and-cancer-2","status":"publish","type":"page","link":"https:\/\/idibell.cat\/en\/research\/cancer-area\/epidemiology-public-health-cancer-prevention-and-palliative-care-program\/infections-and-cancer-2\/","title":{"rendered":"Infections and Cancer"},"content":{"rendered":"\n

\n\t\tInfections and Cancer\n\t<\/h1>\n

\n\t\tSummary\n\t<\/h3>\n\t

The Infections and Cancer group focusses on the fight between viruses and hosts, from an evolutionary perspective: the antiviral mechanisms which animals have developed and the antiviral strategies which have contributed to virus selection. It researches the connection between infection and cancer, as exemplified by the human papilloma virus (HPV).<\/p>\n

925<\/h2>\n

Publications<\/h2>\n\t\t\t\t\"hpv_causing_cervical_cancer\"\n\t\t\t\t\tStrategic lines<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\tHuman papilloma virus (HPV) and genital cancer.
\nHPV and cancer of the oesophagus, oral cavity, skin, vagina, vulva, penis and anus.
\nHepatotropic viruses (hepatitis B and C virus – HBV, HCV) and cancer of the liver.
\nTrials on HPV vaccination and intervention studies on cancer prevention.
\nInfectious aetiology of malignant lymphomas.
\nWHO\/ICO HPV and Cervical Cancer Information Centre.
\nDevelopment of logistics instruments for coordination and diffusion of information regarding viruses and cancer.
\nScreening and prevention of genital cancer.
\nEvaluation of virus detection technologies.
\nFinancial modelling and evaluation of cancer prevention measures.\n\t\t\t\t\t
Selected Publications<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t

– Robles C, Bruni L, Acera A, Riera JC, Prats L, Poljak M, Mlakar J, Valencak AO, Eriksson T, Lehtinen M, Louvanto K, Hortlund M, Dillner J, Faber MT, Munk C, Kjaer SK, Petry KU, Denecke A, Xu L, Arbyn M, Cadman L, Cuzick J, Dalstein V, Clavel C, de Sanjose S, Bosch FX. Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European Countries. Am. J. Prev. Med. 2021;60(4):478-487. doi:10.1016\/j.amepre.2020.08.032. IF:5,04.<\/p>\n

– Cocco P, Satta G, Meloni F, Pilia I, Ahmed F, Becker N, Casabonne D, de Sanjose S, Foretova L, Maynadie M, Nieters A, Staines A, ‘t Mannetje A, Zucca M, Ennas MG, Campagna M, De Matteis S, Benavente Y. Occupational exposure to organic dust and risk of lymphoma subtypes in the EPILYMPH case-control study. SCAND J WORK ENV HEA. 2021;47(1):42-51. doi:10.5271\/sjweh.3925. IF:5,02.<\/p>\n

– Morina D, Fernandez Fontelo A, Cabana A, Puig P, Monfil L, Brotons M, Diaz M. Quantifying the under-reporting of uncorrelated longitudal data: the genital warts example. BMC Med Res Methodol. 2021;21(1):6-6. doi:10.1186\/s12874-020-01188-4. IF:4,62.<\/p>\n

– Frias Gomez J, Tovar E, Vidal A, Murgui L, Ib\u00e1\u00f1ez R, Peremiquel Trillas P, Paytubi S, Baixeras N, Zanca A, Ponce J, Pineda M, Brunet J, de Sanjos\u00e9 S, Bosch FX, Matias Guiu X, Alemany L, Costas L, Screenwide T. Sensitivity of cervical cytology in endometrial cancer detection in a tertiary hospital in Spain. Cancer Med. 2021;10(19):6762-6766. doi:10.1002\/cam4.4217. IF:4,45.<\/p>\n

– Ferreiro Iglesias A, McKay JD, Brenner N, Virani S, Lesseur C, Gaborieau V, Ness AR, Hung RJ, Liu G, Diergaarde B, Olshan AF, Hayes N, Weissler MC, Schroeder L, Bender N, Pawlita M, Thomas S, Pring M, Dudding T, Kanterewicz B, Ferris R, Thomas S, Brhane Y, D\u00edez Obrero V, Milojevic M, Smith Byrne K, Mariosa D, Johansson MJ, Herrero R, Boccia S, Cadoni G, Lacko M, Holc\u00e1tov\u00e1 I, Ahrens W, Lagiou P, Lagiou A, Polesel J, Simonato L, Merletti F, Healy CM, Hansen BT, NYG\u00c5RDM, Conway DI, Wright S, Macfarlane TV, Robinson M, Alemany L, Agudo A, Znaor A, Amos CI, Waterboer T, Brennan P. Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer. Nat Commun. 2021;12(1):5945-5945. doi:10.1038\/s41467-021-26151-9. IF:14,92.<\/p>\n\t\t\t\t\tSelected Projects<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t

CEE21039.\u00a0PERCH: PartnERship to Contrast HPV<\/strong>. COMISSI\u00d3 EUROPEA. Budget: 409468,03. 2022-2025. PI: Brotons Agull\u00f3, Maria.<\/p>\n

MCI22005.\u00a0WOMEC ADVANCED : NUEVAS APROXIMACIONES PARA EL DIAGN\u00d3STICO DE C\u00c1NCER DE ENDOMETRIO<\/strong>. Ministerio de Ciencia e Innovaci\u00f3n. Budget: 194288. 2022-2025. PI: Costas Caudet, Laura.<\/p>\n

19CEE002.\u00a0HEADSpAcE: Translational studies of HEAD and neck cancer in South America and Europe<\/strong>. COMISSI\u00d3 EUROPEA. Budget: 249985. 2019-2023. PI: Alemany Vilches, Laia.<\/p>\n

PNJ22019.\u00a0Reduction of VIral InFectivity and Transmission in HPV positive women before and after vaccination with GARDASIL-9<\/strong>.\u00a0The effect in oral and anal body fluids and after 1- or 2- vaccine doses (RIFT-HPV II)<\/strong>. MERCK SHARP & DOHME ESPA\u00d1A S.A.. Budget: 140478,25. 2021- . PI: Bosch Jos\u00e9, Francesc Xavier.<\/p>\n

FIS21057.\u00a0Human papillomavirus protection index (HPV-PI)<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 47190. 2022-2024. PI: Bruni Coccoz, Laia.<\/p>\n\t\t\t\t\"Laia-Alemany22\"\n

\n\t\tAlemany Vilches, Maria Eulalia\n\t<\/h4>\n

\n\t\t\n\t\tmalemany@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n

\n\t\tPrincipal investigators\n\t<\/h2>\n\t\t\t\t\"Laia-Alemany22\"\n

\n\t\tAlemany Vilches, Maria Eulalia\n\t<\/h4>\n

\n\t\t\n\t\tmalemany@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"delphine-casabonne\"\n

\n\t\tCasabonne, Delphine\n\t<\/h4>\n

\n\t\t\n\t\tdcasabonne@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"Claudia-Robles-Hellin\"\n

\n\t\tRobles Hellin, Claudia\n\t<\/h4>\n

\n\t\t\n\t\tcrobles@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"bosch-jose-fcoJavier\"\n

\n\t\tBosch Jose, FcoJavier\n\t<\/h4>\n

\n\t\t\n\t\txbosch@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"Raquel-Iba\u00f1ez\"\n

\n\t\tIb\u00e1\u00f1ez P\u00e9rez, Raquel\n\t<\/h4>\n

\n\t\t\n\t\tribanez@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"Maria-Brotons-Agullo\"\n

\n\t\tBrotons Agull\u00f3, Maria\n\t<\/h4>\n

\n\t\t\n\t\tmbrotons@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"Laia-Bruni22\"\n

\n\t\tBruni Coccoz, Laia\n\t<\/h4>\n

\n\t\t\n\t\tlbruni@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"Mireia-Diaz-Sanchis\"\n

\n\t\tD\u00edaz Sanch\u00eds, Mireia\n\t<\/h4>\n

\n\t\t\n\t\tmdiaz@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"Miguel-\u00c1ngel-Pav\u00f3n-Ribas\"\n

\n\t\tPavon Ribas, Miquel Angel\n\t<\/h4>\n

\n\t\t\n\t\tmpavon@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"Laura-Costas-Caudet\"\n

\n\t\tCostas Caudet, Laura\n\t<\/h4>\n

\n\t\t\n\t\tlcostas@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n

\n\t\tRELATED LINKS\n\t<\/h4>\n

\n\t\t\n\t\tHPV CENTRE\n\t\t<\/a>\n\t<\/h4>\n

\n\t\t\n\t\t@MejorSinCancer\n\t\t<\/a>\n\t<\/h4>\n

\n\t\t\n\t\t@Laura_Costas_\n\t\t<\/a>\n\t<\/h4>\n

\n\t\tTeam\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tGroup leaders \t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tPrincipal investigators \t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tClinical researchers\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tPostdoctoral researchers\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tPredoctoral researchers\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tScientific support\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tManagement support\t\t\t\t<\/a>\n\t\t\t\t\t\tGroup leaders \n\t\t\t\t\t\t\t\t\t\t\t